» Articles » PMID: 20195508

The Genetic Interpretation of Area Under the ROC Curve in Genomic Profiling

Overview
Journal PLoS Genet
Specialty Genetics
Date 2010 Mar 3
PMID 20195508
Citations 178
Authors
Affiliations
Soon will be listed here.
Abstract

Genome-wide association studies in human populations have facilitated the creation of genomic profiles which combine the effects of many associated genetic variants to predict risk of disease. The area under the receiver operator characteristic (ROC) curve is a well established measure for determining the efficacy of tests in correctly classifying diseased and non-diseased individuals. We use quantitative genetics theory to provide insight into the genetic interpretation of the area under the ROC curve (AUC) when the test classifier is a predictor of genetic risk. Even when the proportion of genetic variance explained by the test is 100%, there is a maximum value for AUC that depends on the genetic epidemiology of the disease, i.e. either the sibling recurrence risk or heritability and disease prevalence. We derive an equation relating maximum AUC to heritability and disease prevalence. The expression can be reversed to calculate the proportion of genetic variance explained given AUC, disease prevalence, and heritability. We use published estimates of disease prevalence and sibling recurrence risk for 17 complex genetic diseases to calculate the proportion of genetic variance that a test must explain to achieve AUC = 0.75; this varied from 0.10 to 0.74. We provide a genetic interpretation of AUC for use with predictors of genetic risk based on genomic profiles. We provide a strategy to estimate proportion of genetic variance explained on the liability scale from estimates of AUC, disease prevalence, and heritability (or sibling recurrence risk) available as an online calculator.

Citing Articles

Exon 1 methylation status of CDH13 is associated with decreased overall survival and distant metastasis in patients with postoperative colorectal cancer.

Xiang P, Li P, Yuan X, Zhao X, Xiao Z, Chen B Discov Oncol. 2024; 15(1):725.

PMID: 39611998 PMC: 11607350. DOI: 10.1007/s12672-024-01604-x.


MicroRNA binding site variants-new potential markers of primary osteoporosis in men and women.

Yalaev B, Deev R, Tyurin A, Salakhov R, Smirnov K, Eremkina A Front Genet. 2024; 15:1470310.

PMID: 39411371 PMC: 11473367. DOI: 10.3389/fgene.2024.1470310.


R2ROC: an efficient method of comparing two or more correlated AUC from out-of-sample prediction using polygenic scores.

Momin M, Wray N, Lee S Hum Genet. 2024; 143(9-10):1193-1205.

PMID: 38902498 DOI: 10.1007/s00439-024-02682-1.


Genome Sequencing in an Individual Presenting with 22q11.2 Deletion Syndrome and Juvenile Idiopathic Arthritis.

de Oliveira-Sobrinho R, Appenzeller S, Holanda I, Heleno J, Jorente J, The Rare Genomes Project Consortium Genes (Basel). 2024; 15(4).

PMID: 38674447 PMC: 11049871. DOI: 10.3390/genes15040513.


Breast and bowel cancers diagnosed in people 'too young to have cancer': A blueprint for research using family and twin studies.

Hopper J, Li S, MacInnis R, Dowty J, Nguyen T, Bui M Genet Epidemiol. 2024; 48(8):433-447.

PMID: 38504141 PMC: 11589006. DOI: 10.1002/gepi.22555.


References
1.
Maher B . Personal genomes: The case of the missing heritability. Nature. 2008; 456(7218):18-21. DOI: 10.1038/456018a. View

2.
Risch N . The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev. 2001; 10(7):733-41. View

3.
Youngson N, Whitelaw E . Transgenerational epigenetic effects. Annu Rev Genomics Hum Genet. 2008; 9:233-57. DOI: 10.1146/annurev.genom.9.081307.164445. View

4.
Marenberg M, Risch N, Berkman L, Floderus B, de Faire U . Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994; 330(15):1041-6. DOI: 10.1056/NEJM199404143301503. View

5.
Lu Q, Elston R . Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet. 2008; 82(3):641-51. PMC: 2664997. DOI: 10.1016/j.ajhg.2007.12.025. View